MODERN STRATEGIES FOR THE TREATMENT OF SECRETORY OTITIS MEDIA IN PATIENTS WITH POST-COVID SYNDROME

Authors:

Abstract:

The purpose of the study was to evaluate the use of topical corticosteroid therapy as a promising method of treating patients with post-COVID secretory otitis media. A prospective, open-label study was conducted in 28 patients (mean age 36.4±8.7 years) with secretory otitis media lasting more than three weeks. Clinical outcomes were assessed using otoscopy, tympanometry, audiometry and symptom scales at baseline, 1 week, 4 weeks, 12 weeks and 6 months. During the observation period, it was proved that local administration of betamethasone dipropionate in the area of the tuberous roller is a promising additional treatment for secretory otitis media in patients with COVID-19 and demonstrates better clinical outcomes compared to standard therapy.

Keywords:

secretory otitis media Eustachian tube post-COVID syndrome betamethasone dipropionate corticosteroids local therapy mucociliary clearance

References:

1. Hariuk HI, Kulikova OO, Lozova YuV, Chumakova AV, Davydenko VL. Statystychnyi analiz diahnostyky ta likuvannia seroznoho serednoho otytu u ditei. Mizhnarodnyi medychnyi zhurnal. 2017;4:62-65. [in Ukrainian].
2. Shydlovska TA, Bezeha MI, Volkova TM, Bezeha BM. Terminy vynyknennia i tryvalosti skarh shchodo sensornykh system u osib, yaki perekhvorily na COVID-19. Otorynolarynholohiia. 2024;2(7):27-31. [in Ukrainian].
3. Almufarrij I, Munro KJ. One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms. Int J Audiol. 2021 Dec;60(12):935-945. doi: 10.1080/14992027.2021.1896793.
4. Bhatta S, Sharma S, Sharma D, Maharjan L, Bhattachan S, Sah MK, et al. Study of Hearing Status in COVID-19 Patients: A Multicentered Review. Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3036-3042. doi: 10.1007/s12070-021-02710-w.
5. Den Dunnen J, Bauwens A, Versfeld NJ, Goderie T. Post-COVID-19 dizziness associated with a patulous eustachian tube. BMJ Case Rep. 2025 Jun 24;18(6):e265008. doi: 10.1136/bcr-2025-265008.
6. Fu X, Wang Z, Chen B, Sun H, Lyu J, Shao J, et al. Detection of SARS-CoV-2 virus in middle ear effusions and its association with otitis media with effusion. J Med Virol. 2024 Mar;96(3):e29545. doi: 10.1002/jmv.29545.
7. Gunasekera H. The wicked problem of otitis media: summary of recent systematic reviews on otitis media with effusion. Paediatr Respir Rev. 2025 Apr 26:S1526-0542(25)00050-8. doi: 10.1016/j.prrv.2025.04.008.
8. Kaidashev I, Shlykova O, Izmailova O, Torubara O, Yushchenko Y, Tyshkovska T, et al. Host gene variability and SARS-CoV-2 infection: A review article. Heliyon. 2021 Aug;7(8):e07863. doi: 10.1016/j.heliyon.2021.e07863.
9. Liang X, Zhang B, Ding Y, Guan Y, Zhou P, Deng Y, et al. Clinical observation of Otitis Media Secretory during Covid-19. Otol Neurotol. 2024 Jun 1;45(5):475-481. doi: 10.1097/MAO.0000000000004158.
10. Maharaj S, Bello Alvarez M, Mungul S, Hari K. Otologic dysfunction in patients with COVID-19: A systematic review. Laryngoscope Investig Otolaryngol. 2020 Nov 17;5(6):1192-1196. doi: 10.1002/lio2.498.
11. Marom T, Pitaro J, Shah UK, Torretta S, Marchisio P, Kumar AT, et al. Otitis Media Practice During the COVID-19 Pandemic. Front Cell Infect Microbiol. 2022 Jan 7;11:749911. doi: 10.3389/fcimb.2021.749911.
12. Zhang Y, Liu J, Yang F, He Y, Yan S, Bai Y, et al. COVID-19-related secretory otitis media in the omicron era: a case series. Eur Arch Otorhinolaryngol. 2023 Oct;280(10):4697-4700. doi: 10.1007/s00405-023.

Publication:

«World of Medicine and Biology» Vol. 21 No. 93 (2025) , с. 33-36
УДК 616.284-002.153-06:616.98:578.834:616-08

DOI:

https://doi.org/10.26724/2079-8334-2025-3-93-33-36